We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Ultrasound Guided Artificial Insemination (UGAI)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00809952
Recruitment Status : Completed
First Posted : December 17, 2008
Last Update Posted : December 17, 2008
Sponsor:
Information provided by:

Study Description
Brief Summary:
The purpose of this study is to ascertain whether using ultrasound guidance during intrauterine insemination (IUI) could increase pregnancy rates.

Condition or disease Intervention/treatment Phase
Insemination Procedure: recombinant FSH Phase 4

Study Design

Study Type : Observational
Groups and Cohorts

Group/Cohort Intervention/treatment
Recombinat FSH Procedure: recombinant FSH


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • The woman's inclusion criteria in our IUI program were at least one patent tube, normal cavity, basal FSH < 10 mU/mL and age under 40 years.
  • IUI with husband's sperm (IUI-H) was indicated when, after sperm preparation, at least 5 million motile spermatozoa were recovered; this was performed in 58 cases (79.45%).
  • In the remaining 15 cases (20.55%), IUI was performed with donor sperm (IUI-D) either because of azoospermia (n=6) failure to recover spermatozoa during testicular biopsy (n=5) or in women without a male partner (n=4).

Exclusion Criteria:

  • Previous infertility treatments had been carried out.
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00809952


Locations
Spain
Human Reproduction Unit
Cruces-Baracaldo, Basque Country, Spain, 48903
Sponsors and Collaborators
Hospital de Cruces
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00809952     History of Changes
Other Study ID Numbers: HUMREP-08-0656
First Posted: December 17, 2008    Key Record Dates
Last Update Posted: December 17, 2008
Last Verified: December 2008